J. Lansen

642 total citations
18 papers, 317 citations indexed

About

J. Lansen is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, J. Lansen has authored 18 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cancer Research. Recurrent topics in J. Lansen's work include Protease and Inhibitor Mechanisms (5 papers), Blood properties and coagulation (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). J. Lansen is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Blood properties and coagulation (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). J. Lansen collaborates with scholars based in Italy, France and United States. J. Lansen's co-authors include Agnese Molinari, Tiziano Bandiera, Mario Varasi, Claes Post, J.P. Maffrand, Gaetano Orsini, Piero Olliaro, Monica Longo, Guy Mazué and Marco Brughera and has published in prestigious journals such as European Journal of Biochemistry, Biochemical Pharmacology and Thrombosis and Haemostasis.

In The Last Decade

J. Lansen

17 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Lansen Italy 11 113 68 53 52 50 18 317
M Ayrault-Jarrier France 13 172 1.5× 39 0.6× 20 0.4× 31 0.6× 102 2.0× 44 506
Sudipta Biswas United States 10 155 1.4× 51 0.8× 18 0.3× 17 0.3× 64 1.3× 12 364
Rie Fujita Japan 11 135 1.2× 59 0.9× 13 0.2× 19 0.4× 24 0.5× 19 353
S S Levinson United States 12 202 1.8× 75 1.1× 36 0.7× 19 0.4× 17 0.3× 28 437
Romina Pecce Italy 8 81 0.7× 66 1.0× 13 0.2× 8 0.2× 20 0.4× 9 345
C. Sacchetti Italy 13 149 1.3× 60 0.9× 12 0.2× 16 0.3× 24 0.5× 50 535
Farisa Syeda Canada 7 236 2.1× 36 0.5× 19 0.4× 10 0.2× 37 0.7× 9 377
RA Johnson United States 4 124 1.1× 142 2.1× 22 0.4× 32 0.6× 5 0.1× 5 354
Paul J. Spieler United States 5 159 1.4× 31 0.5× 32 0.6× 30 0.6× 22 0.4× 6 415
C. A. L. Stephens United States 9 69 0.6× 13 0.2× 33 0.6× 9 0.2× 20 0.4× 19 289

Countries citing papers authored by J. Lansen

Since Specialization
Citations

This map shows the geographic impact of J. Lansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Lansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Lansen more than expected).

Fields of papers citing papers by J. Lansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Lansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Lansen. The network helps show where J. Lansen may publish in the future.

Co-authorship network of co-authors of J. Lansen

This figure shows the co-authorship network connecting the top 25 collaborators of J. Lansen. A scholar is included among the top collaborators of J. Lansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Lansen. J. Lansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Beria, Italo, Barbara Valsasina, Maria Gabriella Brasca, et al.. (2008). 434 POSTER Antitumoral activity of pyrazoloquinazoline derivatives as potent oral Plk-1 specific inhibitors. European Journal of Cancer Supplements. 6(12). 136–136. 3 indexed citations
2.
Longo, Monica, Marco Brughera, Paolo Colombo, et al.. (2005). Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Reproductive Toxicology. 21(1). 83–93. 71 indexed citations
3.
Bandiera, Tiziano, J. Lansen, Claes Post, & Mario Varasi. (1997). Inhibitors of Aβ Peptide Aggregation as Potential Anti-Aizheimer Agents. Current Medicinal Chemistry. 4(3). 159–170. 19 indexed citations
4.
Bandiera, Tiziano, J. Lansen, Claes Post, & Mario Varasi. (1997). Inhibitors of Aβ peptide aggregation as potential anti-Alzheimer agents. 4(3). 159–170. 17 indexed citations
5.
Breton, Jérôme, et al.. (1995). Prolonged Half-Life in the Circulation of a Chemical Conjugate Between a Pro-Urokinase Derivative and Human Serum Albumin. European Journal of Biochemistry. 231(3). 563–569. 15 indexed citations
6.
Breton, Jérôme, et al.. (1995). Prolonged Half‐Life in the Circulation of a Chemical Conjugate Between a Pro‐Urokinase Derivative and Human Serum Albumin. European Journal of Biochemistry. 231(3). 563–569. 5 indexed citations
7.
Molinari, Agnese, C. Giorgetti, J. Lansen, et al.. (1992). Thrombomodulin Is a Cofactor for Thrombin Degradation of Recombinant Single-Chain Urokinase Plasminogen Activator "In Vitro" and in a Perfused Rabbit Heart Model. Thrombosis and Haemostasis. 67(2). 226–232. 27 indexed citations
8.
9.
Orsini, Gaetano, Anna Brandazza, Paolo Sarmientos, et al.. (1991). Efficient renaturation and fibrinolytic properties of prourokinase and a deletion mutant expressed in Escherichia coli as inclusion bodies. European Journal of Biochemistry. 195(3). 691–697. 27 indexed citations
10.
Naggi, Annamaria, Giangiacomo Torri, Benito Casu, et al.. (1987). “Supersulfated” heparin fragments, a new type of low-molecular weight heparin. Biochemical Pharmacology. 36(12). 1895–1900. 24 indexed citations
11.
Paul, Raymond, Jean Marc Herbert, J.P. Maffrand, et al.. (1987). Inhibition of vascular smooth muscle cell proliferation in culture by pentosan polysulphate and related compounds. Thrombosis Research. 46(6). 793–801. 42 indexed citations
12.
Siè, Piérre, et al.. (1986). Tolerance and Biological Activity of Pentosan Polysulfate After Intramuscular or Subcutaneous Administration for Ten Days in Human Volunteers. Thrombosis and Haemostasis. 55(1). 86–89. 10 indexed citations
13.
Siè, Piérre, J. Lansen, F. Lacheretz, Bruno Verschuère, & B Boneu. (1986). Comparative Turn-Over of Heparin Cofactor II and Antithrombin III in Baboons Influence of Heparin and Pentosan Polysulfate Administration. Thrombosis and Haemostasis. 56(3). 302–307. 8 indexed citations
14.
Roncucci, R., et al.. (1979). Measurement of platelet regeneration time in cardiovascular patients. Thrombosis Research. 14(1). 3–14. 11 indexed citations
15.
Lansen, J., G. Biagi, P. Niebes, John L. Gordon, & R. Roncucci. (1979). Effect of Suloctidil on PgI2 Production and Inhibition of Platelet Aggregation. Thrombosis and Haemostasis. 1 indexed citations
16.
Roncucci, R., et al.. (1979). Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.. PubMed. 29(4). 682–4. 4 indexed citations
17.
Roncucci, R., et al.. (1977). Nonradioactive Semi-Automated Determination of Platelet Survival Time in Man. Thrombosis and Haemostasis. 4 indexed citations
18.
Gaetano, Giovanni de, G. Miragliotta, R. Roncucci, J. Lansen, & G. Lambelin. (1976). Suloctidil: A novel inhibitor of platelet aggregation in human beings. Thrombosis Research. 8(3). 361–371. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Ayrault-Jarrier Breakdown of academic impact, for papers by Sudipta Biswas Breakdown of academic impact, for papers by Rie Fujita Breakdown of academic impact, for papers by S S Levinson Breakdown of academic impact, for papers by Romina Pecce Breakdown of academic impact, for papers by C. Sacchetti Breakdown of academic impact, for papers by Farisa Syeda Breakdown of academic impact, for papers by RA Johnson Breakdown of academic impact, for papers by Paul J. Spieler Breakdown of academic impact, for papers by C. A. L. Stephens
Rankless by CCL
2026